Junyue Xing

1.3k total citations
27 papers, 1.0k citations indexed

About

Junyue Xing is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Junyue Xing has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Junyue Xing's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (4 papers). Junyue Xing is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (4 papers). Junyue Xing collaborates with scholars based in China and United States. Junyue Xing's co-authors include Hao Tang, Wengong Wang, Myriam Gorospe, Zhenyun Liu, Xiaotian Zhang, Jie Yi, Yongfeng Shang, Tanjun Tong, Bin Jiang and Yiwei Liu and has published in prestigious journals such as Circulation, Nature Communications and Molecular and Cellular Biology.

In The Last Decade

Junyue Xing

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyue Xing China 12 616 313 109 106 91 27 1.0k
Xiaojia Tang United States 19 813 1.3× 251 0.8× 113 1.0× 70 0.7× 208 2.3× 46 1.5k
Jiadong Wang China 19 659 1.1× 114 0.4× 241 2.2× 152 1.4× 63 0.7× 60 1.4k
Paul A. Reynolds United Kingdom 24 849 1.4× 204 0.7× 211 1.9× 63 0.6× 108 1.2× 59 1.7k
Lili Jing China 16 676 1.1× 287 0.9× 57 0.5× 40 0.4× 109 1.2× 59 1.2k
Ji Yuan China 14 464 0.8× 214 0.7× 141 1.3× 107 1.0× 99 1.1× 33 831
Ting‐Yi Lin Taiwan 17 806 1.3× 114 0.4× 91 0.8× 145 1.4× 59 0.6× 46 1.3k
Ji Zhang China 19 381 0.6× 92 0.3× 238 2.2× 102 1.0× 108 1.2× 54 1.1k
Takanobu Sato Japan 16 354 0.6× 134 0.4× 140 1.3× 102 1.0× 61 0.7× 72 1.1k
B. Liu China 16 758 1.2× 213 0.7× 124 1.1× 143 1.3× 123 1.4× 53 1.5k
Makoto Sano Japan 20 599 1.0× 117 0.4× 238 2.2× 57 0.5× 54 0.6× 82 1.5k

Countries citing papers authored by Junyue Xing

Since Specialization
Citations

This map shows the geographic impact of Junyue Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyue Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyue Xing more than expected).

Fields of papers citing papers by Junyue Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyue Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyue Xing. The network helps show where Junyue Xing may publish in the future.

Co-authorship network of co-authors of Junyue Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Junyue Xing. A scholar is included among the top collaborators of Junyue Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyue Xing. Junyue Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Qinghe, Lulu Chen, Ruili Gao, et al.. (2025). Polyoxometalates‐derived Pt‐Mo 2 C cluster heterostructure for co‐catalytic alkaline hydrogen evolution reaction. Rare Metals. 44(7). 4701–4711. 2 indexed citations
2.
Jian, Dongdong, Xiaolei Cheng, Datun Qi, et al.. (2025). Nsun2 controls cardiac homeostasis and hypertrophic response by regulating PRKACA expression. Theranostics. 15(6). 2393–2412. 2 indexed citations
3.
Xing, Junyue, Huan Zhao, Xiru Chen, et al.. (2025). Engineered probiotic ameliorates hyperlipidemia and atherosclerosis by secreting PCSK9 nanobodies and regulating gut microbiota. Bioengineering & Translational Medicine. 10(6). e70076–e70076.
4.
Yang, Ranbing, et al.. (2025). Numerical simulation and optimisation of depodding performance in a fresh green soybean harvester. Biosystems Engineering. 253. 104127–104127.
5.
6.
Liu, Chuan‐Fen, et al.. (2024). A Nattokinase‐Loaded Nanozyme for Alleviating Acute Myocardial Infarction via Thrombolysis and Antioxidation. Advanced Healthcare Materials. 14(8). e2402763–e2402763. 4 indexed citations
7.
Li, Zhen, Junyue Xing, Wanjun Zhang, et al.. (2024). An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier. Bioactive Materials. 37. 517–532. 11 indexed citations
8.
Xing, Junyue, Yangfan Xiao, Lu Chen, et al.. (2024). A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosis. Advanced Science. 12(1). e2405597–e2405597. 20 indexed citations
9.
Chen, Xiru, Dongdong Jian, Junyue Xing, et al.. (2024). Targeting OGF/OGFR signal to mitigate doxorubicin-induced cardiotoxicity. Free Radical Biology and Medicine. 223. 398–412. 5 indexed citations
10.
Bai, Qian, Yaoyao Zhou, Tingting Wu, et al.. (2023). Mitochondria-targeting nanozyme alleviating temporomandibular joint pain by inhibiting the TNFα/NF-κB/NEAT1 pathway. Journal of Materials Chemistry B. 12(1). 112–121. 11 indexed citations
11.
Jing, Lin, Xiaolei Cheng, Zhen Li, et al.. (2023). DNMT1 determines osteosarcoma cell resistance to apoptosis by associatively modulating DNA and mRNA cytosine‐5 methylation. The FASEB Journal. 37(12). e23284–e23284. 11 indexed citations
12.
Cheng, Xiaolei, Dongdong Jian, Junyue Xing, et al.. (2023). Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy. Clinical and Translational Medicine. 13(5). e1258–e1258. 10 indexed citations
13.
Wang, Yingying, Baiyan Wang, Yangfan Xiao, et al.. (2023). Baicalin-modified polyethylenimine for miR-34a efficient and safe delivery. Frontiers in Bioengineering and Biotechnology. 11. 1290413–1290413. 2 indexed citations
14.
Cheng, Xiaolei, Junyue Xing, Dongdong Jian, et al.. (2022). CIRBP-OGFR axis safeguards against cardiomyocyte apoptosis and cardiotoxicity induced by chemotherapy. International Journal of Biological Sciences. 18(7). 2882–2897. 11 indexed citations
15.
16.
Wang, Tingting, Junyue Xing, Hao Tang, et al.. (2020). Notch1 signaling mediated dysfunction of bone marrow mesenchymal stem cells derived from cyanotic congenital heart disease. Biochemical and Biophysical Research Communications. 527(4). 847–853. 1 indexed citations
17.
Liu, Yiwei, Junyue Xing, Yongnan Li, et al.. (2019). Chronic hypoxia–induced Cirbp hypermethylation attenuates hypothermic cardioprotection via down-regulation of ubiquinone biosynthesis. Science Translational Medicine. 11(489). 32 indexed citations
18.
Xing, Junyue, Chenxi Mao, Yiwei Liu, et al.. (2018). Hypoxia induces senescence of bone marrow mesenchymal stem cells via altered gut microbiota. Nature Communications. 9(1). 2020–2020. 101 indexed citations
19.
Tang, Hao, Xiuqin Fan, Junyue Xing, et al.. (2015). NSun2 delays replicative senescence by repressing p27 (KIP1) translation and elevating CDK1 translation. Aging. 7(12). 1143–1155. 94 indexed citations
20.
Zhang, Xiaotian, Zhenyun Liu, Jie Yi, et al.. (2012). The tRNA methyltransferase NSun2 stabilizes p16INK4 mRNA by methylating the 3′-untranslated region of p16. Nature Communications. 3(1). 712–712. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojia Tang Breakdown of academic impact, for papers by Jiadong Wang Breakdown of academic impact, for papers by Paul A. Reynolds Breakdown of academic impact, for papers by Lili Jing Breakdown of academic impact, for papers by Ji Yuan Breakdown of academic impact, for papers by Ting‐Yi Lin Breakdown of academic impact, for papers by Ji Zhang Breakdown of academic impact, for papers by Takanobu Sato Breakdown of academic impact, for papers by B. Liu Breakdown of academic impact, for papers by Makoto Sano
Rankless by CCL
2026